Skip to content

Study · Measured the body's own peptide · 2024

1 result

Outcomes of High-Dose Versus Low-Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation: A Randomized Controlled Trial.

Ashoor TM, Abd Elazim AEH, Mustafa ZAE, Anwar MA, Gad IA, Mamdouh Esmat I

Journal of intensive care medicine5 May 2024Cited by 8 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelRandomized controlled trialOther

    In eighty adults with sepsis requiring mechanical ventilation, high-dose enteral vitamin D3 raised serum LL‑37 more than low-dose vitamin D3 by day 7.

    In plain wordsIn ventilated patients with sepsis, high-dose vitamin D raised the body's own LL‑37 levels more than low-dose vitamin D.

    Peptide
    LL-37
    Outcome
    IncreaseChange in serum LL-37 level on day 7 (day 7 minus day 0)
    Study

    n = 80

    Comparator
    Low-dose enteral vitamin D3 (5000 IU, Group II)
    Analysis
    Secondary
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The (day 7-day 0) change in serum PCT and LL-37 levels and SOFA score were significantly different in Group I (P = .010, P < .001, and P < .001, respectively).
    Summary
    increased serum LL-37 levels
    2 context sentences
    Summary · context
    Eighty adult patients with sepsis requiring MV with known vitamin D deficiency were randomly assigned to receive either an enteral 50 000 IU (Group I) or 5000 IU (Group II) vitamin D supplementation.
    Summary · context
    while the change in serum LL-37 levels on day 7, changes in sequential organ failure assessment (SOFA) score, and clinical pulmonary infection score on day 7, MV duration, and hospital length of stay (LOS) were the secondary outcomes

    This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    9 Oct 2026, 12:39 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:56 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.